Literature DB >> 27893354

Summary report of the First International Conference on inhibitors in haemophilia A.

Sebastien Lacroix-Desmazes1, David W Scott2, Jenny Goudemand3, Marijke Van Den Berg4, Michael Makris5, Alice S Van Velzen6, Elena Santagostino7,8,9, David Lillicrap10, Frits R Rosendaal11, Anneliese Hilger12, Zuben E Sauna13, Johannes Oldenburg14, Lorenzo Mantovani14, M Elisa Mancuso7,8, Craig Kessler15, Charles R M Hay16, Paul Knoebl17, Giovanni Di Minno18, Keith Hoots19, Amanda Bok20, Mark Brooker21, Erica Buoso22, Pier Mannuccio Mannucci7, Flora Peyvandi7,8,9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27893354      PMCID： PMC5649967          DOI： 10.2450/2016.0252-16

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  6 in total

Review 1.  Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years.

Authors:  Ezio Zanon; Samantha Pasca
Journal:  Blood Transfus       Date:  2018-02-04       Impact factor: 3.443

2.  Emicizumab for the treatment of haemophilia A: a narrative review.

Authors:  Massimo Franchini; Giuseppe Marano; Ilaria Pati; Fabio Candura; Samantha Profili; Eva Veropalumbo; Francesca Masiello; Liviana Catalano; Vanessa Piccinini; Stefania Vaglio; Simonetta Pupella; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2019-05       Impact factor: 3.443

Review 3.  Factors affecting the quality, safety and marketing approval of clotting factor concentrates for haemophilia.

Authors:  Albert Farrugia; Giancarlo M Liumbruno; Fabio Candura; Samantha Profili; Josephine Cassar
Journal:  Blood Transfus       Date:  2018-09-03       Impact factor: 3.443

Review 4.  Hemophilia Care in the Pediatric Age.

Authors:  Marta Bertamino; Francesca Riccardi; Laura Banov; Johanna Svahn; Angelo Claudio Molinari
Journal:  J Clin Med       Date:  2017-05-19       Impact factor: 4.241

5.  Mutational Profiles of F8 and F9 in a Cohort of Haemophilia A and Haemophilia B Patients in the Multi-ethnic Malaysian Population.

Authors:  Maimiza Zahari; Siti Aishah Sulaiman; Zulhabri Othman; Yasmin Ayob; Faraizah Abd Karim; Rahman Jamal
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-09-01       Impact factor: 2.576

Review 6.  Tolerance to FVIII: Role of the Immune Metabolic Enzymes Indoleamine 2,3 Dyoxigenase-1 and Heme Oxygenase-1.

Authors:  Davide Matino; Sajjad Afraz; George Zhao; Paul Tieu; Marco Gargaro; Francesca Fallarino; Alfonso Iorio
Journal:  Front Immunol       Date:  2020-04-15       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.